Michael S.’s Story | See

See Prescribing Info, including BOXED WARNING & Medication Guide, at https://abbv.ie/RinvoqPI

Michael knows firsthand that eczema in skin of color is often misdiagnosed. Along with topicals and injections that didn’t work for him, Michael struggled to find help. Then came Dr. Ruiz Dasilva, who recommended RINVOQ.

About RINVOQ
USE
RINVOQ is a prescription medicine used to treat adults and children 12 years of age and older with moderate to severe eczema (atopic dermatitis) that did not respond to previous treatment and their eczema is not well controlled with other pills or injections, including biologic medicines, or the use of other pills or injections is not recommended. It is not known if RINVOQ is safe and effective in children under 12 years of age with atopic dermatitis.

Safety Considerations
RINVOQ may cause serious side effects, including:
Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
Tears in the stomach or intestines; changes in certain laboratory test results.

For additional Important Safety Information, visit https://abbv.ie/RinvoqISI

Learn more about RINVOQ for moderate to severe eczema (atopic dermatitis) at https://www.rinvoq.com/atopic-dermatitis